Xiaobin Wu Sells $1.52M of BeOne Medicines Ltd (ONC) — SEC Form 4, Nov 19, 2025

Open-Market Net Sale · SEC Form 4
−$1,518,303

Equity position changed by -0.4%

Reporting Owner
TXN 2025-11-17 · FILED 2025-11-19
Equity Position 985K sh 989,334 → 985,343
Equity Change -0.4% shares held after vs before
Filing Lag 2 business days within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Filing Date
2025-11-19
Report Date
2025-11-17
Accession No.
0001739452-25-000006
Accepted At
2025-11-19 21:57 UTC
Reporting Owner
Name Relationship
Xiaobin Wu CIK 0001739452
COO
Xiaobin Wu at BeOne Medicines Ltd Full insider history
Bought (12 mo) —
Sold (12 mo) $8,753,697
More from this insider at BeOne Medicines Ltd
2026-08-27 Sell -$106,400 View
2026-06-25 Sell -$356,927 View
2026-06-18 Sell -$361,997 View
2026-06-15 Sell -$163,512 View
2026-06-10 Sell -$399,738 View
All filings by this insider at BeOne Medicines Ltd
Non-Derivative Securities Transactions
Title Date Type Shares Price Net Total Post-Txn Ownership
American Depositary SharesF1F2 2025-11-17 S - Sale 3,155 D $380.23 -$1,199,617 836 Direct
American Depositary SharesF1F3 2025-11-17 S - Sale 826 D $381.19 -$314,862 10 Direct
American Depositary SharesF1 2025-11-17 S - Sale 10 D $382.32 -$3,823 0 Direct
Non-Derivative Holdings
Title Shares Held Ownership
Ordinary Shares 968,978 Direct
American Depositary SharesF1 12,365 Direct
American Depositary SharesF1 4,000 Indirect By Wife
Footnotes (3)
F1
Each American Depositary Share represents 13 Ordinary Shares. Show more
F2
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $380.00 to $380.765, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Show more
F3
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $381.115 to $381.88, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Show more
5%+ Holders · 13D/G 2 filers
Other insiders at BeOne Medicines Ltd
All BeOne Medicines Ltd insider activity
GET /v1/forms/4/0001739452-25-000006 API docs
View Original SEC Filing